AVITA Medical, Inc. entered into a $60 million credit agreement on January 13, 2026, with an initial $50 million available immediately and additional funds contingent on meeting revenue requirements. This marks a refinancing of previous debts and includes terms for a warrant to buy shares, affecting future operations and financing.